Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy. [electronic resource]
Producer: 20110603Description: 301-6 p. digitalISSN:- 1326-5377
- Absorptiometry, Photon
- Aged
- Androgen Antagonists -- adverse effects
- Antineoplastic Agents, Hormonal -- adverse effects
- Bone Density -- drug effects
- Combined Modality Therapy
- Diphosphonates -- therapeutic use
- Exercise -- physiology
- Humans
- Life Style
- Male
- Middle Aged
- Osteoporosis -- chemically induced
- Osteoporotic Fractures -- diagnosis
- Practice Guidelines as Topic
- Prognosis
- Prostatic Neoplasms -- drug therapy
- Risk Assessment
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.